Ubrolexin® is a novel, broad spectrum antibiotic treatment delivering a potent bactericidal activity against both gram positive and gram negative mastitis-causing bacteria i.e. on both ends of the pathogen spectrum.

Ubrolexin® is a powerful combination of two effective antibiotics (Cefalexin and Kanamycin) which show a synergistic antibacterial activity: the effect of Cefalexin is enhanced by Kanamycin and vice versa.